Current drug therapy for prostate cancer: an overview. (Record no. 15928805)

MARC details
000 -LEADER
fixed length control field 01463 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515005712.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200602s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1568-0118
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2174/156801105774574658
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Stewart, Alistair B
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060203
245 00 - TITLE STATEMENT
Title Current drug therapy for prostate cancer: an overview.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Current medicinal chemistry. Anti-cancer agents
Date of publication, distribution, etc. Nov 2005
300 ## - PHYSICAL DESCRIPTION
Extent 603-12 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Hormonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bone Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diphosphonates
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Endothelin A Receptor Antagonists
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element ErbB Receptors
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genetic Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms, Hormone-Dependent
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neovascularization, Pathologic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostatic Neoplasms
General subdivision blood supply
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lwaleed, Bashir A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Douglas, David A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Birch, Brian R
773 0# - HOST ITEM ENTRY
Title Current medicinal chemistry. Anti-cancer agents
Related parts vol. 5
-- no. 6
-- p. 603-12
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2174/156801105774574658">https://doi.org/10.2174/156801105774574658</a>
Public note Available from publisher's website

No items available.